By Gatwiri Muthara — 2019
End-of-life doulas provide a new type of caregiving to patients and families.
Read on www.aarp.org
CLEAR ALL
In her New York Times bestseller, Radical Remission: Surviving Cancer Against All Odds, Dr. Kelly A. Turner, founder of the Radical Remission Project, uncovers nine factors that can lead to a spontaneous remission from cancer—even after conventional medicine has failed. While getting her Ph.D.
1
Resurrection Lily shares a story of inheritance and intuition, of what can surface in the body and the spirit when linked by DNA.
Winner of the Pulitzer Prize and a documentary from Ken Burns on PBS, this New York Times bestseller is “an extraordinary achievement” (The New Yorker)—a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles...
This presentation will help patients and their families understand and navigate the various lifestyle and role changes that can occur after a cancer diagnosis.
Pain and suffering can be powerful teachers. When mixed with bravery, they can unlock the secret to an incredible life. For Katie Mazurek, an aggressive stage 3 breast cancer diagnoses at age 33 was the opportunity of a lifetime.
William S.
What can metastatic breast cancer patients teach us about the meaning in life? Based on her research at Stanford University and UCSF, Donna Tran discusses how people can transform and improve their quality of life through meaning-centered psychotherapy.
Clinical psychologist Wendy Lichtenthal of Memorial Sloan-Kettering describes the desire to find meaning from the cancer experience.
In The First Cell, Azra Raza offers a searing account of how both medicine and our society (mis)treats cancer, how we can do better, and why we must. A lyrical journey from hope to despair and back again, The First Cell explores cancer from every angle: medical, scientific, cultural, and personal.
A week after her forty-first birthday, the acclaimed poet Anne Boyer was diagnosed with highly aggressive triple-negative breast cancer.